CENTRAL ADMIXTURE PHARMACY SERVICES, INC

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2013–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	2	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
Polsinelli PC	—	54

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	52
SENATE	41
Food & Drug Administration (FDA)	23
Health & Human Services, Dept of (HHS)	13

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	53

Bills Explicitly Cited (5)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to legislation addressing the federal regulation of pharmacies [Pharmaceutical Compounding Quality and Accountability Act (S. 959); Drug Quality and Security Act, H.R. 3204 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2013 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to legislation addressing the federal regulation of pharmacies [Pharmaceutical Compounding Quality and Accountability Act (S. 959); Drug Quality and Security Act, H.R. 3204 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: S. 959

H.R. 3204113th Congress

Drug Quality and Security Act

2013 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to legislation addressing the federal regulation of pharmacies [Pharmaceutical Compounding Quality and Accountability Act (S. 959); Drug Quality and Security Act, H.R. 3204 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2013 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to legislation addressing the federal regulation of pharmacies [Pharmaceutical Compounding Quality and Accountability Act (S. 959); Drug Quality and Security Act, H.R. 3204 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: S. 959

Show 1 more cited filings

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2013 · second_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to legislation addressing the federal regulation of pharmacies [Pharmaceutical Compounding Quality and Accountability Act (S. 959)]

Client expense: — · Firm income: $20,000

Matched citations: S. 959

Source: Senate LDA

CENTRAL ADMIXTURE PHARMACY SERVICES, INC — Lobbying Disclosure | Poliscope